Switch to
View more

Par Drugs and Chemicals Ltd

PAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹203 cr, stock is ranked 1,725
High RiskStock is 3.44x as volatile as Nifty
165.551.65 (-0.99%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹203 cr, stock is ranked 1,725
High RiskStock is 3.44x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
22.09
PB RatioPB Ratio
3.90
Dividend YieldDiv. Yield
Sector PESector PE
38.16
Sector PBSector PB
4.82
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Par Drugs and Chemicals provides generic drugs. The Company is engaged in the development and manufacturing of Active Pharma Ingredients (APIs) for the domestic market, as well as for exports to international markets

Investor PresentationView older 

Aug 9, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

201920202021202246.4255.9462.9375.262.524.7711.629.22
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Investor Presentation 
Announced OnAug 9, 2022

Par Drugs And Chemicals Limited has informed the Exchange about Investor Presentation | Download

Par Drugs And Chemicals Limited has informed the Exchange about Investor Presentation | Download

Book Closure 
Announced OnAug 1, 2022

Par Drugs And Chemicals Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 03-Sep-2022 to 10-Sep-2022 for the purpose of Meeting. | Download

Par Drugs And Chemicals Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 03-Sep-2022 to 10-Sep-2022 for the purpose of Meeting. | Download

Cash Dividend 
Ex. DateNov 22, 2021

Interim • Div/Share: ₹ 1.25

See all events